Healthcare provider profile · identity verified

Monica Joshi, MD

Family Practice · WILMINGTON, DE · NPI 1235361148

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Warfarin Sodium	Warfarin Sodium	327	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	239	38
Furosemide	Furosemide	229	41
Gabapentin	Gabapentin	221	34
Metoprolol Succinate	Metoprolol Succinate	209	35
Amlodipine Besylate	Amlodipine Besylate	170	30
Atorvastatin Calcium	Atorvastatin Calcium	165	29
Memantine Hcl	Memantine Hcl	154	22
Lisinopril	Lisinopril	153	22
Eliquis	Apixaban	152	27
Donepezil Hcl	Donepezil Hcl	147	20
Sertraline Hcl	Sertraline Hcl	139	17
Famotidine	Famotidine	130	22
Omeprazole	Omeprazole	127	20
Pantoprazole Sodium	Pantoprazole Sodium	125	23
Mirtazapine	Mirtazapine	111	20
Potassium Chloride	Potassium Chloride	110	28
Fluoxetine Hcl	Fluoxetine Hcl	100	suppressed
Trazodone Hcl	Trazodone Hcl	96	16
Nystatin	Nystatin	91	34
Quetiapine Fumarate	Quetiapine Fumarate	84	suppressed
Losartan Potassium	Losartan Potassium	83	14
Fluticasone Propionate	Fluticasone Propionate	82	36
Myrbetriq	Mirabegron	74	suppressed
Carvedilol	Carvedilol	69	12
Montelukast Sodium	Montelukast Sodium	65	suppressed
Doxepin Hcl	Doxepin Hcl	60	suppressed
Baclofen	Baclofen	58	15
Rosuvastatin Calcium	Rosuvastatin Calcium	58	suppressed
Xarelto	Rivaroxaban	58	suppressed
Prednisone	Prednisone	54	27
Buspirone Hcl	Buspirone Hcl	53	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	52	suppressed
Tramadol Hcl	Tramadol Hcl	52	15
Citalopram Hbr	Citalopram Hydrobromide	51	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	51	11
Hydrochlorothiazide	Hydrochlorothiazide	51	suppressed
Glipizide	Glipizide	50	suppressed
Lorazepam	Lorazepam	49	19
Klor-Con M10	Potassium Chloride	47	suppressed
Albuterol Sulfate	Albuterol Sulfate	46	21
Latanoprost	Latanoprost	43	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Simvastatin	Simvastatin	33	suppressed
Jardiance	Empagliflozin	30	suppressed
Methimazole	Methimazole	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Cephalexin	Cephalexin	29	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Methenamine Hippurate	Methenamine Hippurate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Erythromycin	Erythromycin Base	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Atenolol	Atenolol	25	suppressed
Ondansetron Odt	Ondansetron	25	19
Pregabalin	Pregabalin	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	14
Valacyclovir	Valacyclovir Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Insulin Aspart Flexpen	Insulin Aspart	18	suppressed
Metformin Hcl	Metformin Hcl	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Methylprednisolone	Methylprednisolone	15	12
Torsemide	Torsemide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Bupropion Xl	Bupropion Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Digoxin	Digoxin	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Tacrolimus	Tacrolimus	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Donepezil Hcl Odt	Donepezil Hcl	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error